SearchBar Icon

Sleep Apnea Devices Market to Reach Close to $6.5 Billion by 2023

Published Date:   June 2018

Global sleep apnea devices market is expected to reach approximately $6.5 billion by 2023, according to P&S Market Research.

The market is mainly driven by the increasing patient pool for sleep apnea on account of increasing obesity globally, improving patient compliance owing to stringent reimbursement regulations, increasing home sleep testing as well as initiatives to increase awareness globally.

Insights into market segments

Based on product, the sleep apnea devices market has been categorized into diagnostic and therapeutic devices. During the forecast period, the market demand for therapeutic devices is expected to witness faster growth. Therapeutic devices are further categorized into positive airway pressure (PAP) devices, facial interfaces, oral appliances, adaptive servo-ventilators (ASVs), and others. Among all the types of therapeutic devices, PAP devices are expected to exhibit the fastest growth in the sleep apnea therapeutic devices market during the forecast period.

Diagnostic devices are also sub-categorized into polysomnography devices, home sleep testing devices, pulse oximeters, actigraphy devices, sleep screening devices, and respiratory polygraphs. Of all types, polysomnography devices held the largest share in the sleep apnea diagnostic devices market, in 2017.

Sleep laboratories and at-home are the end users in the sleep apnea devices market, where sleep laboratories held the larger share in the market, in 2017. This is attributable to the availability of trained staff in these laboratories who can monitor sleeping patterns effectively.

Browse report overview with detailed TOC on "Sleep Apnea Devices Market by Product (Diagnostic [Positive Airway Pressure (PAP) Devices, Facial Interfaces, Oral Appliances, Adaptive Servo-Ventilators (ASVs)], Therapeutic [Polysomnography Devices, Home Sleep Testing Devices, Pulse Oximeters, Actigraphy Devices, Sleep Screening Devices, Respiratory Polygraphs]), by End User (Sleep Laboratories, At-Home), by Geography (U.S., Canada, U.K., Germany, France, Japan, China, Brazil, Mexico, Saudi Arabia, U.A.E., South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2016–2023" at:

Market is predicted to witness the fastest growth in APAC

During the forecast period, the sleep apnea devices market is expected to witness the fastest growth in Asia-Pacific (APAC), owing to the increasing prevalence of sleep apnea disorders, the large undiagnosed pool in countries such as India, and initiatives by the government and other private organizations to raise awareness regarding sleep disorders.

For instance, in March 2018, Philips India Ltd., a subsidiary of Koninklijke Philips NV, conducted a survey “Better Sleep, Better Health: A Global Look at Why We’re Still Falling Short on Sleep”. According to it, 15,000 adults across 13 countries (U.S., U.K., Germany, Poland, France, India, China, Australia, Colombia, Argentina, Mexico, Brazil and Japan) reported certain results for sleep disorders— 61% of the respondents reported medical issues impacting sleep. Of them, insomnia afflicted 26% and snoring kept awake 21% of the respondents. Worrying (58%) and technology distractions (26%) were the other major impediments to good sleep. In India, 19% of the adults reported overlapping of work hours with normal sleep time (shift-work-sleep disorder) as a key barrier to sleep. Another 32% of the adults from India reported technology as a major sleep distractor.

Market players are focusing on product innovations to expand their business

In order to increase their market share, key players in the sleep apnea devices industry are developing new products to expand their product portfolio. For instance, in May 2018, Fisher & Paykel Healthcare launched F&P SleepStyle, a CPAP device used in the treatment of obstructive sleep apnea (OSA). The device offers built-in cellular and Bluetooth connectivity options, which ensures that both patients and clinicians receive information when required. SleepStyle will be available in New Zealand and Australia in June, and in other countries, upon receipt of the relevant regulatory clearances.

Some of the other major players operating in the sleep apnea devices market are ResMed Inc., Koninklijke Philips N.V., SleepMEd Inc., SomnoMed Ltd., Compumedics Limited, Löwenstein Medical GmbH & Co. KG., BMC Medical Co. Ltd., Drive DeVilbiss Healthcare, and Braebon Medical Corporation.


Market Segmentation by Product

  • Therapeutic Devices
    • Positive Airway Pressure (PAP) Devices
    • Facial Interfaces
    • Oral Appliances
    • Adaptive Servo-Ventilators (ASVs)
    • Others
  • Diagnostic Devices
    • Polysomnography Devices
    • Home Sleep Testing Devices
    • Pulse Oximeters
    • Actigraphy Devices
    • Sleep Screening Devices
    • Respiratory Polygraphs

Market Segmentation by End User

  • Sleep Laboratories
  • At-Home

Market Segmentation by Geography

  • North America sleep apnea devices market
    • By product
    • By end user
    • By country
      • U.S. sleep apnea devices market
        • By product
        • By end user
      • Canada sleep apnea devices market
        • By product
        • By end user
  • Europe sleep apnea devices market
    • By product
    • By end user
    • By country – U.K., Germany, France, and Rest of Europe
  • Asia-Pacific (APAC) sleep apnea devices market
    • By product
    • By end user
    • By country – Japan, China, and Rest of APAC
  • Latin America (LATAM) sleep apnea devices market
    • By product
    • By end user
    • By country – Brazil, Mexico, and Rest of LATAM
  • Middle East and Africa (MEA) sleep apnea devices market
    • By product
    • By end user
    • By country – Saudi Arabia, U.A.E, South Africa and Rest of MEA